These 4 Dow Jones industrial shares are now in trends in down trends

The weakness displayed in the price diagrams of this important, great capitalization of Dow Jones Industrials is not a good sign of the entire stock markets. After a strong 2024, it is an adaptation for Wall Street analysts to see how bad these big names only play two months after the new year.

These former guides have problems finding the upward trend.

By downward trend I mean that the price of everyone does not seem to be able to supply yourself on or over the late 2024 -high. This is the first piece of price diagram analysis, but there is more. These shares have dropped below the considerable average values, in which it is easy to carry out the direction of the trend at short notice and in the long term.

4 Dow Jones Industrials in waste

Caterpillar (Nyse: Cat)

November 204 High is close to $ 415. The January high of almost 410 US dollars hits the sale and is not higher. You can see how the sliding 50-day average (the blue line) trends weakness down until mid-December 2024.

It is not a bullish look that the price is among the two moving average values ​​and it is decreased deeply of almost 350 US dollars at the beginning of January. A test of September 2024 low close to 325 US dollars can take place next.

United Healthcare (NYSE: UNH)

The stock reached a highlight of almost $ 630 in early November. The new test in early December made it up to only $ 620, a new one. After the long waste to the deep of the mid-December, Unitedhealth could not rise more than $ 555 before the sale began.

The sliding 50-day average crossed at the gliding average of 200 days at the end of January and remains below it. The big prices in December -with a large volume in the last week, since investors seemed to be able to reach the level “Just sell”.

Microsoft (NASD: Msft)

The name of the big cap cannot make it high over the early July 2024. The attempt to do this in December 2024 fails. The sliding 50-day average has turned down and seems to cross under the sliding 200-day average, which signals the intensity of the weakness.

Note that the price dropped under the previous support levels of the beginning of November 2024 and which tests deep from the beginning of September 2024. If a serious sale begins, this can be tested deeply in August 2024 near 380 US dollars.

Merck (NYSE: MRK)

Although the stock has gathered in the past few days, the price on the way has to look bullish again. The sliding 50-day average crossed in early September 2024 under the sliding 200-day average and has stayed below since then.

The GAP Down in early February 2025 took Merck on November in mid -November. If the gap is filled this month, the stock would increase over the sliding 50-day average.

Further analysis and comment at johnnavin.substack.com.